Canadian Medical Research
CMR is an independent, patient-led institute for precision pharmacology and treatment-effectiveness research. We study the evidence conventional care structures tend to set aside — off-label use, treatment-resistant presentations, and the mechanisms behind them — and hold patient autonomy as a founding principle of that work.
Treat the symptom. Question the disease.
Research organized around the patient, not the label
Canadian Medical Research is an independent research organization. We are not a clinic and do not provide medical treatment; our work is the collection, review, and publication of evidence on treatment effectiveness — including evidence that sits outside a drug or protocol's approved indication.
Our position is that approval and label status describe a regulatory history, not the limits of what evidence exists. We publish what we find, cited and clearly distinguished from clinical recommendation, so that patients, clinicians, and the bodies that oversee them can make informed decisions from the same information.
- Status
- Independent, patient-led research organization
- Jurisdiction
- Canada
- Focus
- Precision pharmacology & treatment-effectiveness evidence
- Correspondence
- office@canadianmedicalresearch.com
The principles our research is conducted under
These are not aspirational — they govern how findings are gathered, reviewed, and published.
Patient autonomy
The patient is the primary authority over their own treatment decisions. Our role is to inform that decision, never to substitute for it.
Non-paternalism
We do not withhold evidence on the assumption that a patient is better off not knowing it. Information is presented plainly, with its limitations stated alongside it.
Against gatekeeping
Approval and label status are treated as information, not as a verdict. Off-label and investigational evidence is reviewed with the same rigor as approved indications, not dismissed for lacking one.
Evidence integrity
Findings are sourced and cited. Mechanism, effectiveness, and approval status are always reported as three distinct things — never conflated into a single claim.
Where our review work is concentrated
Precision & genetic pharmacology
Metabolizer status and dosing evidence as a starting point rather than an afterthought.
Gut-brain & vagal science
Enteric signalling, vagal tone, and visceral pathways underweighted in conventional review.
Treatment-resistant presentations
Including movement disorders such as akathisia, which are frequently under-documented.
Off-label & investigational evidence
Reviewed and cited on its own merits, with approval status reported separately.
Contact the Institute
CMR welcomes correspondence from patients, clinicians, researchers, and regulatory or governmental bodies. Please identify the nature of your inquiry so it can be routed appropriately.
Canada